Business Wire

Legora Attracts $80 Million Series B Funding as Top Global Law Firms and Legal Teams Rush to Adopt Its Collaborative AI

21.5.2025 10:00:00 CEST | Business Wire | Press Release

Share

Today, Legora announces an $80 million funding round led by ICONIQ and General Catalyst, with continued support from existing investors Redpoint Ventures, Benchmark, and Y Combinator. This latest round is a strong endorsement of Legora’s product quality, velocity and the remarkable traction it has achieved globally—underscored by its rapid progression from inception to Series B in under two years.

The deal comes as adoption of legal AI surges across the world. Legora is at the forefront of this shift - with lawyers across 250 firms and legal teams in 20 markets globally making daily use of its platform to review and research with precision, draft smarter, and collaborate seamlessly.

Legora operates out of New York, London, and Stockholm, with 100 employees drawn from some of the world’s leading global law firms and tech companies.

Max Junestrand, CEO and founder of Legora said: “The investment is a clear validation of the value our product is delivering to lawyers around the world. While we weren’t actively seeking funding, the strength of our growth, product, and client partnerships naturally attracted this backing, and I am ecstatic to have ICONIQ and General Catalyst with us on the journey as Seth and Jeannette join our board.

“This enables us to double down on what’s always set Legora apart — deep collaboration with our clients — and to scale innovation and accelerate product development, ensuring we leverage rapidly changing technology to meet the needs of the legal profession. We’re committed to building a product that not only solves today’s challenges but continues to adapt and deliver long-term value.”

Seth Pierrepont, General Partner at ICONIQ commented: “From our first conversation with Max and Sigge, it was immediately evident to us that they are building with rare clarity and velocity, creating a platform that doesn’t just fit into legal workflows — it elevates them, and understands the nuance and pace of modern legal teams. In just two years, they’ve delivered an enterprise-grade product that’s already trusted by hundreds of law firms and in-house legal teams globally. We’re proud to partner with Legora as they scale what we believe is a category-defining platform that’s reshaping how legal work gets done.”

Jeannette zu Fürstenberg, Managing Director and Head of Europe at General Catalyst said: “Legora is driving AI transformations in a highly specialized industry. With an outstanding product, rapid adoption by top-tier firms, and a founder who combines rare product instinct with exceptional execution, as we see it, Legora is redefining how legal work gets done. We’re excited to support Max and the team as they scale this category-defining platform.”

Legora’s collaborative approach to developing and embedding its AI underpins its success to date. More than just a platform, Legora is a true partner to clients, working alongside them from the first interaction to company-wide rollout and beyond. This ensures Legora’s solution is intuitively matched to client needs, and that engagement is broad and deep from day one; with the technology embraced by junior lawyers right up to managing partners across enterprises.

By building with lawyers, not just for them, Legora has accelerated adoption and delivered immediate value. Its AI platform is making a measurable impact at top law firms and in-house teams, powering multiple work-critical use cases and helping teams get to the heart of key issues in hours rather than days — enabling improved and more confident client responses with less write-offs.

Mary O’Carroll, Goodwin’s Chief Operating Officer commented: “Legora represents exactly the kind of strategic technology investment that keeps Goodwin at the forefront of legal excellence. We've been very pleased with the initial results we have seen since partnering with them in March, and we look forward to continuous improvement in how our lawyers use Legora to deliver legal services and insights to clients.”

Max Junestrand added:“AI, simply put, is a historic opportunity for legal professionals to get real leverage on their expertise and know-how. We have observed tasks such as reviewing data-rooms go from weeks to hours with no loss in accuracy - making human-machine intelligence and collaboration the de facto way of working. Both law firms and legal teams are already reaping the benefits of these advancements at scale.”

About Legora

Legora is the world’s first truly collaborative AI for lawyers serving over 250 law firms and in-house legal teams across 20 countries. Co-founded by CEO Max Junestrand and CTO Sigge Labor, Legora now has offices in New York, Stockholm and London and has raised $120M in funding to date. Legora works with prestigious clients such as Cleary Gottlieb, Goodwin and Bird & Bird - helping lawyers review, draft and work more effectively with AI. Legora.com

About ICONIQ

ICONIQ is a global investment firm catalyzing opportunity through extraordinary community. Our venture and growth investment platform partners with visionaries defining the future of their industries to achieve uncommon outcomes. Drawing on the wisdom and connectivity of our extraordinary community, we support our portfolio companies’ success at every inflection point, from early traction to IPO and beyond. Our robust portfolio includes Adyen, Airbnb, Alibaba, Alteryx, Automattic, BambooHR, Braze, Chime, Collibra, Coupa, Datadog, Docusign, Gitlab, Marqeta, Miro, Procore, Red Ventures, Relativity, ServiceTitan, Snowflake, Sprinklr, Truckstop, Uber, Wolt, and Zoom, among others. For more information, please visit www.iconiqcapital.com/growth.

About General Catalyst

General Catalyst is a global investment and transformation company that partners with the world’s most ambitious entrepreneurs to drive resilience and applied AI.

We support founders with a long-term view who challenge the status quo, partnering with them from seed to growth stage and beyond.

With offices in San Francisco, New York City, Boston, Berlin, Bangalore, and London, we have supported the growth of 800+ businesses, including Airbnb, Anduril, Applied Intuition, Commure, Glean, Guild, Gusto, Helsing, Hubspot, Kayak, Livongo, Mistral, Ramp, Samsara, Snap, Stripe, Sword, and Zepto.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250521743643/en/

Contacts

Notes to editors
For media enquiries, please contact:
press@legora.com
legora@firstlightgroup.io

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye